Burkehill Global Management’s Cidara Therapeutics CDTX Stock Holding History

Burkehill Global Management’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-50,000	Closed	-$11M	–	188
2025 Q4	$11M	Hold	50,000	–	–	0.73%	42
2025 Q3	$4.79M	Hold	50,000	–	–	0.27%	87
2025 Q2	$2.44M	Buy	+50,000	New	+$1.2M	0.18%	81

Burkehill Global Management's CDTX Position: Q1 2026 in Review

Burkehill Global Management sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 50,000 shares — an estimated $11M sold.

Burkehill Global Management first reported a position in CDTX in Q2 2025 and held it in 3 quarters. The position peaked at $11M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Burkehill Global Management reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Burkehill Global Management sold 50,000 Cidara Therapeutics shares in Q1 2026, an estimated $11M.
Burkehill Global Management first reported a position in Cidara Therapeutics in Q2 2025 and held it in 3 quarters.
Burkehill Global Management's Cidara Therapeutics position peaked at $11M in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Burkehill Global Management's 13F filing for Q1 2026, filed 15 May 2026.